HOSPITAL UNIVERSITARIO RUBER

Département

Foto de HOSPITAL UNIVERSITARIO RUBER

Foto de Silvia

Silvia
Antolín Novoa

Publications dans lesquelles il/elle collabore avec Silvia Antolín Novoa (4)

2023

Trastuzumab deruxtecan versus trastuzumab emtansine in patients with HER2-positive metastatic breast cancer: updated results from DESTINY-Breast03, a randomised, open-label, phase 3 trial
The Lancet, Vol. 401, Núm. 10371, pp. 105-117

2020

Correction: NSABP FB-7: A phase II randomized neoadjuvant trial with paclitaxel + trastuzumab and/or neratinib followed by chemotherapy and postoperative trastuzumab in HER2+ breast cancer (Breast Cancer Research (2019) 21 (133) DOI: 10.1186/s13058-019-1196-y)
Breast Cancer Research

2019

NSABP FB-7: A phase II randomized neoadjuvant trial with paclitaxel + trastuzumab and/or neratinib followed by chemotherapy and postoperative trastuzumab in HER2+ breast cancer
Breast Cancer Research, Vol. 21, Núm. 1

2017

Intrinsic subtypes and gene expression profiles in primary and metastatic breast cancer
Cancer Research, Vol. 77, Núm. 9, pp. 2213-2221